ABPN NDD common mistakes
ABPN NDD · Understand the traps and how to avoid them.
When a vignette describes a child with developmental delay plus a specific dysmorphic feature or congenital anomaly, the candidate jumps to a named genetic syndrome before checking whether the described features actually co-occur in that syndrome.
Pattern-recognition pressure under time limits leads candidates to match on a single salient feature (e.g., a long face, an inverted nipple, a heart murmur) rather than verifying the full phenotype, and rare-syndrome names are more memorable than the discriminating features.
What to do instead
Before committing to a syndrome, explicitly list the features in the vignette and ask which are obligate versus variable for the syndrome you are considering; if a stated feature is not part of that syndrome's spectrum, eliminate it and re-rank.
Selecting a diagnosis of autism spectrum disorder for a toddler with language delay and repetitive behavior without first confirming that social-communication deficits are present across contexts and not better explained by hearing loss, global developmental delay, or a social-pragmatic pattern alone.
Candidates conflate any repetitive behavior or any language delay with ASD and skip the differential that the diagnostic criteria require be excluded, especially sensory impairment and intellectual disability.
What to do instead
Apply the two-domain criterion explicitly (persistent social communication/interaction deficits AND restricted repetitive patterns), and always name the exclusion workup (audiologic evaluation, developmental testing) before finalizing ASD.
Treating a milestone that is merely at the outer edge of normal as automatically abnormal, or conversely reassuring on a milestone that is clearly outside the accepted limit, without referencing the standard age ranges for gross motor, fine motor, language, and social milestones.
Candidates memorize a single 'average' age per milestone and lack the normal range, so they misjudge borderline presentations and miss true red flags such as no words by 16 months or no walking by 18 months.
What to do instead
Anchor each milestone question to explicit limits (e.g., no babbling by 9 months, no single words by 16 months, no two-word phrases by 24 months, no walking by 18 months) and treat loss of skills at any age as abnormal regardless of range.
Confusing regression (loss of previously acquired skills) with a plateau or slow acquisition, and then choosing a static encephalopathy or isolated language disorder instead of pursuing a neurodegenerative or epileptic encephalopathy workup.
Regression is a high-yield discriminator but candidates underweight the history detail that skills were once present, and they default to common developmental diagnoses.
What to do instead
On any vignette, ask 'were these skills ever present?' If yes and now lost, prioritize regression workup (metabolic, neurodegenerative, EEG for epileptic encephalopathy such as Landau-Kleffner or CSWS) over static diagnoses.
Choosing a medication or dosing for ADHD, irritability in ASD, or tics without checking age indication, formulation, baseline cardiac or growth monitoring, and whether nonpharmacologic first-line treatment has been addressed.
Candidates recall drug classes but not the age thresholds, monitoring requirements, and sequencing of behavioral versus pharmacologic intervention, and they overlook that some agents are off-label by age.
What to do instead
For each psychopharmacology item, state the approved age range, the required baseline and follow-up monitoring (e.g., growth and cardiovascular parameters for stimulants, metabolic and movement monitoring for antipsychotics), and confirm whether parent training or behavioral therapy is the indicated first step.
Missing the indicated first-tier genetic or metabolic test for a child with global developmental delay or intellectual disability, instead ordering a broad or low-yield panel first.
Test-ordering hierarchies change over time and candidates rely on outdated sequencing, so they pick karyotype or a broad metabolic screen when chromosomal microarray or fragile X testing is the recommended first tier.
What to do instead
Memorize the tiered workup: chromosomal microarray (and fragile X DNA testing) as first-tier for unexplained GDD/ID; exome/genome sequencing next; metabolic screening reserved for specific clues (regression, episodic decompensation, dysmorphism with organomegaly).
Overlooking hearing and vision screening as the cause of a speech, language, or behavioral presentation, and proceeding directly to neurologic or psychiatric diagnosis.
Sensory impairment mimics many neurodevelopmental disorders and candidates treat audiologic evaluation as already done or irrelevant.
What to do instead
For any language delay, inattention, or social concern, explicitly confirm that objective hearing testing (and vision screening where relevant) has been completed before attributing findings to a central disorder.
Misattributing a focal neurologic sign, asymmetric tone, or early hand preference to a behavioral or developmental variant rather than recognizing a possible cerebral palsy or structural lesion requiring imaging.
Candidates associate cerebral palsy only with obvious spasticity or known perinatal injury and miss subtle early asymmetry, and they underweight early handedness as a red flag.
What to do instead
Treat hand preference before 18 months, asymmetric tone or reflexes, and persistent fisting as red flags prompting neuroimaging and CP evaluation rather than watchful waiting.
Managing a neurodevelopmental concern in isolation without addressing the systems-of-care elements (early intervention referral, school-based IEP/504 services, transition planning, family and caregiver support) that the question is actually testing.
Candidates focus on the medical diagnosis and treatment and treat care-coordination, educational entitlement, and transition as background rather than the tested decision.
What to do instead
When a stem asks 'next step' in a developmental context, weigh the systems answer (referral to early intervention under IDEA Part C for under-3, school-based evaluation for 3 and older, transition planning in adolescence) as a legitimate and often correct choice alongside medical workup.
Applying adult neurologic frameworks (e.g., adult stroke localization, adult psychiatric criteria, adult dosing) directly to infants and children without adjusting for the developing nervous system and age-specific presentations.
Candidates carry over adult-trained heuristics, and the developmental timeline (myelination, synaptogenesis, plasticity) changes both the clinical expression and the appropriate intervention.
What to do instead
For each item, explicitly ask how the same lesion or disorder would present at this age; recall that the immature brain shifts seizure semiology, exam findings, and drug handling, and select age-specific criteria and dosing.